HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,718,550 | -68.5% | 45,000 | -53.1% | 0.02% | -70.2% |
Q4 2022 | $5,462,400 | +43.9% | 96,000 | 0.0% | 0.06% | +32.6% |
Q3 2022 | $3,796,000 | -10.1% | 96,000 | 0.0% | 0.04% | 0.0% |
Q2 2022 | $4,224,000 | +231.0% | 96,000 | +200.0% | 0.04% | +290.9% |
Q1 2022 | $1,276,000 | +10533.3% | 32,000 | +2566.7% | 0.01% | – |
Q2 2014 | $12,000 | -98.6% | 1,200 | -98.2% | 0.00% | -100.0% |
Q1 2014 | $839,000 | -50.3% | 66,075 | -41.4% | 0.00% | -60.0% |
Q4 2013 | $1,689,000 | +3.6% | 112,697 | -23.7% | 0.01% | 0.0% |
Q3 2013 | $1,631,000 | +145.6% | 147,697 | +76.6% | 0.01% | +150.0% |
Q2 2013 | $664,000 | – | 83,622 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |